Talphera, Inc.
Talphera, Inc. (TLPH) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · TLPH · as of Jun 8, 2026
Key Statistics
Explore Talphera, Inc. Data
tlph stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
tlph competitorsTLPH
APUS
COSM
IBIO
INTS
ITRMStock Performance
Full HistoryAbout Talphera, Inc.
Talphera, Inc. is a specialty pharmaceutical company focused on developing and commercializing therapeutic products intended for use in carefully monitored medical environments. Their lead experimenta…
what is talphera, inc. · tlph stock overview · talphera, inc. company profile · who is talphera, inc. ceo · tlph NASDAQ · talphera, inc. headquarters · talphera, inc. business segments
About Stock Overview & Key Data
Talphera, Inc. (TLPH) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Feb 11, 2011. As of the latest trading session, TLPH stock price is $0.85, with a market capitalization of $17.4M. The stock has returned +64.40% over the past 12 months and -25.72% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Talphera, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Talphera, Inc. reported revenue of $28000.00 and net income of -$14.3M. For detailed data — including Talphera, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Talphera, Inc. (TLPH) stock price is $0.85. The stock is traded on NASDAQ under the ticker symbol TLPH. The 52-week range is $0.38 – $1.57.